TRANSCEND FL: Phase 2 Study Results of Lisocabtagene Maraleucel (Liso-Cel) in Patients (pts) with Relapsed/refractory (R/R) Follicular Lymphoma (FL)
ONCOLOGY RESEARCH AND TREATMENT（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined